E-cigarette Usage in UK Reaches Record High Levels

Aug.12.2024
E-cigarette Usage in UK Reaches Record High Levels
The e-cigarette use among UK adults has reached a record high, with 11% using them, totaling 5.6 million people.

According to a report from the Shropshire Star on August 12th, the use of e-cigarettes among adults in the UK has reached a record high. The latest data shows that 11% of UK adults use e-cigarettes, equating to 5.6 million people.


According to data from Action on Smoking and Health (ASH) in the UK, approximately 53% of e-cigarette users, which is equivalent to 3 million people, were previously traditional cigarette smokers. Currently, the proportion of people who use both traditional cigarettes and e-cigarettes has increased from 17% in 2021 to 32% in 2024, equivalent to 2.2 million people.


Ash's deputy chief executive Hazel Cheeseman said:


Smoking remains the biggest preventable killer in the UK, and e-cigarettes are one of the important tools to help smokers quit in order to achieve a smoke-free nation for both current and future generations.


Professor Sanjay Agrawal, Special Advisor on Tobacco Issues at the Royal College of Physicians and Consultant in Respiratory and Intensive Care Medicine at the University Hospitals of Leicester NHS Trust, added:


In the past few years, almost all of the patients I have encountered who have successfully quit smoking have done so by using e-cigarettes, without which they may have not been able to quit. E-cigarettes have been used by quit smoking services and the NHS to support smokers, but we can still more widely use this tool to help millions of people who are still smoking to quit.


According to reports, in July of this year, the Labour government restarted its plan to introduce the Tobacco and E-Cigarette Bill, which could gradually raise the age limit for purchasing tobacco and prevent anyone born after January 1, 2009 from legally purchasing tobacco. The bill could also impose restrictions on the flavors, packaging, and display of e-cigarettes.


Ms. Chisman emphasized that the proposed e-cigarette legislation should focus on preventing children from using e-cigarettes, rather than adults who are looking to quit smoking. She added:


In recent years, millions of people have successfully quit smoking by using e-cigarettes, extending their healthy lifespan and boosting national productivity. There is an urgent need for stricter regulations on e-cigarettes, but it is important that these regulations target teenage e-cigarette use specifically, without hindering their use as a smoking cessation aid.


Henry Gregg, Director of External Affairs for the British Lung Foundation, said:


Quitting smoking can be very difficult, and it is great to see that many smokers are finding e-cigarettes to be a very effective tool for quitting. However, in order to help more smokers quit, the government must increase investment in local smoking cessation services. In recent years, these services have faced significant cuts, but they have excelled in supporting people to quit smoking permanently and address the deadly consequences of smoking.


According to a survey, half of smokers believe that e-cigarettes are as harmful as traditional cigarettes, and 60% of non-e-cigarette users who smoke also share the same view.


A spokesperson for the UK Department of Health and Social Care stated:


Although e-cigarettes can be an effective tool for quitting smoking, health advice clearly states that non-smoking children and adults should never use e-cigarettes. The upcoming Tobacco and E-Cigarette Act will protect future generations from the harm of tobacco and nicotine, saving thousands of lives. By establishing a healthier society, it will also contribute to building a healthier economy.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Global tobacco leaf markets diverged sharply in 2026, with India cutting authorised FCV production amid oversupply while Malawi faced a supply shortfall. U.S. demand improved in some leaf categories, but growers in Brazil, Colombia, Tanzania and Zimbabwe faced pressure from prices, buyer access, costs and weather. With nicotine consumption patterns also shifting, 2027 will test whether supply, demand and grower profitability can move back toward balance.
Oct.26
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives